Eloxx Pharmaceuticals Inc (ELOX)
0.8025
0.00 (0.00%)
USD |
OTCM |
Apr 23, 09:30
Eloxx Pharmaceuticals Total Assets (Quarterly): 6.042M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 6.042M |
| June 30, 2023 | 5.993M |
| March 31, 2023 | 7.20M |
| December 31, 2022 | 21.12M |
| September 30, 2022 | 26.88M |
| June 30, 2022 | 32.94M |
| March 31, 2022 | 43.62M |
| December 31, 2021 | 45.14M |
| September 30, 2021 | 55.38M |
| June 30, 2021 | 60.61M |
| March 31, 2021 | 20.37M |
| December 31, 2020 | 26.48M |
| September 30, 2020 | 32.94M |
| June 30, 2020 | 39.92M |
| March 31, 2020 | 47.04M |
| December 31, 2019 | 58.95M |
| September 30, 2019 | 68.06M |
| June 30, 2019 | 79.04M |
| March 31, 2019 | 56.89M |
| December 31, 2018 | 50.72M |
| September 30, 2018 | 56.54M |
| June 30, 2018 | 64.36M |
| March 31, 2018 | 19.16M |
| September 30, 2017 | 6.591M |
| June 30, 2017 | 5.845M |
| Date | Value |
|---|---|
| March 31, 2017 | 5.842M |
| December 31, 2016 | 5.807M |
| September 30, 2016 | 7.013M |
| June 30, 2016 | 9.226M |
| March 31, 2016 | 10.56M |
| December 31, 2015 | 15.64M |
| September 30, 2015 | 19.44M |
| June 30, 2015 | 19.55M |
| March 31, 2015 | 16.92M |
| December 31, 2014 | 18.55M |
| September 30, 2014 | 28.14M |
| June 30, 2014 | 33.33M |
| March 31, 2014 | 10.96M |
| December 31, 2013 | 11.10M |
| September 30, 2013 | 5.815M |
| June 30, 2013 | 7.098M |
| March 31, 2013 | 6.892M |
| December 31, 2012 | 5.464M |
| September 30, 2012 | 6.260M |
| June 30, 2012 | 6.955M |
| March 31, 2012 | 8.635M |
| December 31, 2011 | 6.857M |
| September 30, 2011 | 8.272M |
| June 30, 2011 | 8.597M |
| March 31, 2011 | 11.09M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
5.993M
Minimum
Jun 2023
79.04M
Maximum
Jun 2019
37.65M
Average
36.43M
Median
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
| Theriva Biologics Inc | 55.22M |
| Oragenics Inc | 4.966M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 26.09M |
| Shareholders Equity (Quarterly) | -20.05M |